1. Economic Evaluations During Early (Phase II) Drug Development

   • Dyfrig A. Hughes
   • Tom Walley

   Leading Article 17 September 2012 Pages: 1069 - 1077

   

2. Quality-of-Life Assessment in Patients with Benign Prostatic Hyperplasia

   • Jose-Emilio Batista-Miranda
   • Marta De la Cruz Diez
   • Humberto Villavicencio

   Review Article 17 September 2012 Pages: 1079 - 1090

   

3. Cost Effectiveness of Treatment Options in Advanced Breast Cancer in the UK

   • Ruth E. Brown
   • John Hutton
   • Anita Burrell

   Original Research Article 17 September 2012 Pages: 1091 - 1102

   

4. Cost-Effectiveness Analysis and the Consistency of Decision Making

   • Bethan George
   • Anthony Harris
   • Andrew Mitchell

   Original Research Article 17 September 2012 Pages: 1103 - 1109

   

5. Paclitaxel

   • Greg L. Plosker
   • Miriam Hurst

   Adis Pharmacoeconomic Drug Evaluation 17 September 2012 Pages: 1111 - 1134

   

6. Piperacillin/Tazobactam

   • Melissa Young
   • Greg L. Plosker

   Adis Pharmacoeconomic Drug Evaluation 17 September 2012 Pages: 1135 - 1175